ClinicalTrials.Veeva

Menu

Developing Resiliency and Exercise Using AI-based Messaging (DREAM)

Mass General Brigham logo

Mass General Brigham

Status

Not yet enrolling

Conditions

Diabetes Mellitus Type 2

Treatments

Behavioral: DREAM

Study type

Interventional

Funder types

Other

Identifiers

NCT07225283
2025P002706

Details and patient eligibility

About

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

Full description

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program. DREAM is an 8-week message-based program to promote physical activity and well-being in adults with type 2 diabetes. In DREAM, participants will complete twice weekly messaging sessions, in which they will set weekly physical activity goals and perform activities to enhance well-being. The primary outcome is feasibility (measured by number of messaging sessions successfully transmitted) and acceptability (measured by 0-10 utility ratings). Secondary outcomes include preliminary impact on physical activity and psychological and health-related outcomes.

Enrollment

20 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
  • Suboptimal physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
  • Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser

Exclusion criteria

  • An unrelated condition limiting physical activity
  • Participation in any other programs focused on physical activity or well-being
  • A cognitive disturbance precluding participation or informed consent
  • Current pregnancy or plan to become pregnant in the next 16 weeks
  • Inability to speak/write fluently in English
  • Use of non-basal insulin

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

DREAM
Experimental group
Description:
Participants will engage in twice weekly, interactive messaging sessions with DREAM, a computer-based messaging system designed to help people engage in more physical activity and improve overall well-being. In the first session of each week, participants will set a physical activity goal and learn a new positive psychology topic. They will review goals and topics from the prior week. In the second session, participants will be reminded of the goals set during the first messaging session earlier that week. The program will run for eight weeks.
Treatment:
Behavioral: DREAM
Wait-list control
No Intervention group
Description:
Participants in the wait-list control condition will engage in usual medical care for eight weeks, then will complete the DREAM program.

Trial contacts and locations

1

Loading...

Central trial contact

Christopher M Celano, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems